Portunus trituberculatus isolate SZX2019 chromosome 24, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030094.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC123508319, transcript variant X2
uncharacterized LOC123508319, transcript variant X1
uncharacterized LOC123508319, transcript variant X5
uncharacterized LOC123508319, transcript variant X3
uncharacterized LOC123508319, transcript variant X4
dual specificity protein kinase shkE-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
uncharacterized LOC123508321, transcript variant X2
uncharacterized LOC123508321, transcript variant X1
uncharacterized protein LOC123508321 isoform X1
uncharacterized protein LOC123508321 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
prostatic spermine-binding protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
prostatic spermine-binding protein-like, transcript variant X1
prostatic spermine-binding protein-like isoform X2
uncharacterized LOC123508048, transcript variant X2
uncharacterized LOC123508048, transcript variant X1
uncharacterized protein LOC123508048 isoform X2
uncharacterized protein LOC123508048 isoform X1
uncharacterized LOC123508049, transcript variant X1
uncharacterized LOC123508049, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
acidic leucine-rich nuclear phosphoprotein 32 family member B-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cilia- and flagella-associated protein 251-like
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic-like, transcript variant X4
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic-like, transcript variant X1
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic-like, transcript variant X2
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic-like, transcript variant X3
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic-like isoform X4
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic-like isoform X3
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic-like isoform X2
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic-like isoform X1
transmembrane protein 243-like, transcript variant X5
transmembrane protein 243-like, transcript variant X1
transmembrane protein 243-like, transcript variant X2
transmembrane protein 243-like, transcript variant X3
transmembrane protein 243-like, transcript variant X4
F-box/SPRY domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123508065, transcript variant X5
uncharacterized LOC123508065, transcript variant X4
uncharacterized LOC123508065, transcript variant X3
uncharacterized LOC123508065, transcript variant X2
uncharacterized LOC123508065, transcript variant X1
uncharacterized protein LOC123508065 isoform X5
uncharacterized protein LOC123508065 isoform X4
uncharacterized protein LOC123508065 isoform X3
uncharacterized protein LOC123508065 isoform X2
uncharacterized protein LOC123508065 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 67% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123508055, transcript variant X3
uncharacterized protein LOC123508055 isoform X3
uncharacterized LOC123508055, transcript variant X2
uncharacterized protein LOC123508055 isoform X2
uncharacterized LOC123508055, transcript variant X1
uncharacterized protein LOC123508055 isoform X1
uncharacterized LOC123508055, transcript variant X4
uncharacterized protein LOC123508055 isoform X4
zinc finger protein 235-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger protein 235-like, transcript variant X1
zinc finger protein 235-like, transcript variant X3
zinc finger protein 235-like, transcript variant X2
zinc finger protein 235-like, transcript variant X8
zinc finger protein 235-like, transcript variant X6
zinc finger protein 235-like, transcript variant X5
zinc finger protein 235-like, transcript variant X7
zinc finger protein 235-like, transcript variant X4
aminopeptidase N-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aminopeptidase N-like, transcript variant X2
aminopeptidase N-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SH2B adapter protein 1-like, transcript variant X3
SH2B adapter protein 1-like, transcript variant X2
SH2B adapter protein 1-like, transcript variant X1
spectrin alpha chain-like, transcript variant X1
spectrin alpha chain-like, transcript variant X5
spectrin alpha chain-like, transcript variant X4
spectrin alpha chain-like, transcript variant X6
spectrin alpha chain-like, transcript variant X2
spectrin alpha chain-like, transcript variant X3
sarcosine dehydrogenase, mitochondrial-like, transcript variant X2
sarcosine dehydrogenase, mitochondrial-like, transcript variant X1
uncharacterized LOC123508390, transcript variant X2
uncharacterized LOC123508390, transcript variant X1
uncharacterized LOC123508390, transcript variant X3
fibrous sheath CABYR-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sarcosine dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC123508266, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123508266, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC123508266 isoform X1
uncharacterized protein LOC123508266 isoform X2
uncharacterized LOC123508256, transcript variant X2
uncharacterized LOC123508256, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
guanine nucleotide exchange factor DBS-like, transcript variant X7
guanine nucleotide exchange factor DBS-like isoform X7
guanine nucleotide exchange factor DBS-like, transcript variant X9
guanine nucleotide exchange factor DBS-like, transcript variant X1
guanine nucleotide exchange factor DBS-like, transcript variant X2
guanine nucleotide exchange factor DBS-like, transcript variant X3
guanine nucleotide exchange factor DBS-like, transcript variant X4
guanine nucleotide exchange factor DBS-like isoform X1
guanine nucleotide exchange factor DBS-like isoform X2
guanine nucleotide exchange factor DBS-like isoform X3
guanine nucleotide exchange factor DBS-like isoform X4
guanine nucleotide exchange factor DBS-like isoform X9
guanine nucleotide exchange factor DBS-like, transcript variant X5
guanine nucleotide exchange factor DBS-like isoform X5
LOW QUALITY PROTEIN: uncharacterized protein LOC123508481
guanine nucleotide exchange factor DBS-like, transcript variant X8
guanine nucleotide exchange factor DBS-like isoform X8
guanine nucleotide exchange factor DBS-like, transcript variant X10
guanine nucleotide exchange factor DBS-like isoform X10
guanine nucleotide exchange factor DBS-like, transcript variant X6
guanine nucleotide exchange factor DBS-like isoform X6
uncharacterized LOC123508267, transcript variant X1
uncharacterized LOC123508267, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123508267, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
microtubule-associated protein futsch-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC123508112, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123508112, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123508112, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC123508112, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123508112, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
serine/arginine repetitive matrix protein 2-like
LOW QUALITY PROTEIN: serine/arginine repetitive matrix protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: Fanconi anemia group D2 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
LOW QUALITY PROTEIN: uncharacterized protein LOC123508137
ubiquitin recognition factor in ER-associated degradation protein 1-like, transcript variant X1
ubiquitin recognition factor in ER-associated degradation protein 1-like, transcript variant X3
ubiquitin recognition factor in ER-associated degradation protein 1-like, transcript variant X2
ubiquitin recognition factor in ER-associated degradation protein 1-like, transcript variant X4
ubiquitin recognition factor in ER-associated degradation protein 1-like isoform X1
ubiquitin recognition factor in ER-associated degradation protein 1-like isoform X2
uncharacterized transmembrane protein DDB_G0289901-like
glycine-rich cell wall structural protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
ADP-ribosylation factor 1, transcript variant X6
ADP-ribosylation factor 1, transcript variant X1
ADP-ribosylation factor 1, transcript variant X3
ADP-ribosylation factor 1, transcript variant X4
ADP-ribosylation factor 1, transcript variant X2
ADP-ribosylation factor 1, transcript variant X5
tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A-like, transcript variant X1
tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A-like, transcript variant X2
tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A-like
serine-rich adhesin for platelets-like, transcript variant X5
serine-rich adhesin for platelets-like, transcript variant X4
serine-rich adhesin for platelets-like, transcript variant X3
serine-rich adhesin for platelets-like, transcript variant X1
serine-rich adhesin for platelets-like, transcript variant X2
serine-rich adhesin for platelets-like isoform X4
serine-rich adhesin for platelets-like isoform X3
serine-rich adhesin for platelets-like isoform X2
serine-rich adhesin for platelets-like isoform X1
phosphatidylethanolamine-binding protein 1-like, transcript variant X1
phosphatidylethanolamine-binding protein 1-like, transcript variant X3
phosphatidylethanolamine-binding protein 1-like, transcript variant X2
phosphatidylethanolamine-binding protein 1-like isoform X1
phosphatidylethanolamine-binding protein 1-like isoform X2
WAS/WASL-interacting protein family member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
regulator of telomere elongation helicase 1 homolog
PH and SEC7 domain-containing protein-like, transcript variant X1
PH and SEC7 domain-containing protein-like, transcript variant X2
PH and SEC7 domain-containing protein-like, transcript variant X3
PH and SEC7 domain-containing protein-like isoform X1
PH and SEC7 domain-containing protein-like isoform X2
PH and SEC7 domain-containing protein-like isoform X3
lactosylceramide 4-alpha-galactosyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytoplasmic phosphatidylinositol transfer protein 1-like
LOW QUALITY PROTEIN: WD repeat-containing protein 36-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
proline-rich receptor-like protein kinase PERK2
neuroblast differentiation-associated protein AHNAK-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: neuroblast differentiation-associated protein AHNAK-like
peptidyl-prolyl cis-trans isomerase FKBP4-like, transcript variant X2
peptidyl-prolyl cis-trans isomerase FKBP4-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP4-like isoform X2
peptidyl-prolyl cis-trans isomerase FKBP4-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
LOW QUALITY PROTEIN: valine--tRNA ligase-like
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger BED domain-containing protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
regulator of G-protein signaling 7-binding protein-like, transcript variant X1
regulator of G-protein signaling 7-binding protein-like, transcript variant X2
uncharacterized protein LOC123508208 isoform X1
regulator of G-protein signaling 7-binding protein-like isoform X2
LOW QUALITY PROTEIN: microtubule-associated protein futsch-like
LOW QUALITY PROTEIN: cytochrome P450 CYP12A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
hemicentin-2-like, transcript variant X4
hemicentin-2-like, transcript variant X1
hemicentin-2-like, transcript variant X2
hemicentin-2-like, transcript variant X3
tryptophan--tRNA ligase, cytoplasmic-like, transcript variant X1
tryptophan--tRNA ligase, cytoplasmic-like, transcript variant X2
tryptophan--tRNA ligase, cytoplasmic-like
high mobility group protein HMG-I/HMG-Y-like, transcript variant X2
high mobility group protein HMG-I/HMG-Y-like, transcript variant X3
high mobility group protein HMG-I/HMG-Y-like, transcript variant X1
high mobility group protein HMG-I/HMG-Y-like isoform X2
high mobility group protein HMG-I/HMG-Y-like isoform X1
putative ferric-chelate reductase 1 homolog, transcript variant X2
putative ferric-chelate reductase 1 homolog, transcript variant X1
putative ferric-chelate reductase 1 homolog isoform X2
putative ferric-chelate reductase 1 homolog isoform X1
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: treacle protein-like
uncharacterized protein DDB_G0292186-like
lipoyl synthase, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
lipoyl synthase, mitochondrial-like, transcript variant X1
protein dispatched-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein dispatched-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein dispatched-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protein FAM102B-like, transcript variant X1
protein FAM102B-like, transcript variant X4
protein FAM102B-like, transcript variant X5
protein FAM102B-like, transcript variant X3
protein FAM102B-like, transcript variant X2
serine/arginine repetitive matrix protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/arginine repetitive matrix protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/arginine repetitive matrix protein 2-like isoform X1
serine/arginine repetitive matrix protein 2-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00319
rho guanine nucleotide exchange factor 16-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
rho guanine nucleotide exchange factor 16-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
rho guanine nucleotide exchange factor 26-like isoform X1
rho guanine nucleotide exchange factor 16-like isoform X2
LMBR1 domain-containing protein 2 homolog, transcript variant X2
LMBR1 domain-containing protein 2 homolog, transcript variant X3
LMBR1 domain-containing protein 2 homolog, transcript variant X1
LMBR1 domain-containing protein 2 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123508476
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
receptor-transporting protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
receptor-transporting protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC123508276 isoform X2
receptor-transporting protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
receptor-transporting protein 3-like isoform X1
FAD-dependent oxidoreductase domain-containing protein 1-like, transcript variant X1
FAD-dependent oxidoreductase domain-containing protein 1-like, transcript variant X2
FAD-dependent oxidoreductase domain-containing protein 1-like
nose resistant to fluoxetine protein 6-like, transcript variant X2
nose resistant to fluoxetine protein 6-like, transcript variant X1
nose resistant to fluoxetine protein 6-like isoform X1
nose resistant to fluoxetine protein 6-like isoform X2
vacuolar protein sorting-associated protein 13-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X11
vacuolar protein sorting-associated protein 13-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X14
vacuolar protein sorting-associated protein 13-like, transcript variant X8
vacuolar protein sorting-associated protein 13-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13-like isoform X1
vacuolar protein sorting-associated protein 13-like isoform X2
vacuolar protein sorting-associated protein 13-like isoform X3
vacuolar protein sorting-associated protein 13-like isoform X6
vacuolar protein sorting-associated protein 13-like isoform X8
vacuolar protein sorting-associated protein 13-like isoform X9
vacuolar protein sorting-associated protein 13-like isoform X7
vacuolar protein sorting-associated protein 13-like isoform X10
vacuolar protein sorting-associated protein 13-like isoform X5
vacuolar protein sorting-associated protein 13-like isoform X4
vacuolar protein sorting-associated protein 13-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13C-like isoform X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
3'-5' ssDNA/RNA exonuclease TatD-like, transcript variant X1
3'-5' ssDNA/RNA exonuclease TatD-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
RAD52 motif-containing protein 1-like, transcript variant X3
RAD52 motif-containing protein 1-like, transcript variant X1
RAD52 motif-containing protein 1-like isoform X1
RAD52 motif-containing protein 1-like isoform X3
RAD52 motif-containing protein 1-like, transcript variant X2
RAD52 motif-containing protein 1-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
INO80 complex subunit C-like, transcript variant X2
INO80 complex subunit C-like, transcript variant X1
PDF receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PDF receptor-like, transcript variant X1
PDF receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
irregular chiasm C-roughest protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
irregular chiasm C-roughest protein-like isoform X5
irregular chiasm C-roughest protein-like isoform X6
irregular chiasm C-roughest protein-like isoform X1
irregular chiasm C-roughest protein-like isoform X3
irregular chiasm C-roughest protein-like isoform X2
irregular chiasm C-roughest protein-like isoform X4
irregular chiasm C-roughest protein-like isoform X7
irregular chiasm C-roughest protein-like isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 10 member 6-like, transcript variant X1
solute carrier family 10 member 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 10 member 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 10 member 6-like isoform X2
solute carrier family 10 member 6-like isoform X1
solute carrier family 10 member 6-like isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 10 member 6-like
retinoid-inducible serine carboxypeptidase-like
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase 33-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 33-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 33-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 33-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 33-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 33-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 33-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 33-like isoform X3
ubiquitin carboxyl-terminal hydrolase 33-like isoform X4
ubiquitin carboxyl-terminal hydrolase 33-like isoform X2
ubiquitin carboxyl-terminal hydrolase 33-like isoform X1
peroxisomal membrane protein 11C-like, transcript variant X2
peroxisomal membrane protein 11C-like, transcript variant X1
peroxisomal membrane protein 11C-like, transcript variant X4
peroxisomal membrane protein 11C-like, transcript variant X3
peroxisomal membrane protein 11C-like isoform X1
peroxisomal membrane protein 11C-like isoform X2
TBC1 domain family member 15-like, transcript variant X1
TBC1 domain family member 15-like, transcript variant X3
TBC1 domain family member 15-like, transcript variant X4
TBC1 domain family member 15-like, transcript variant X2
TBC1 domain family member 15-like isoform X1
TBC1 domain family member 15-like isoform X3
TBC1 domain family member 15-like isoform X4
TBC1 domain family member 15-like isoform X2
protein Star-like, transcript variant X2
protein Star-like, transcript variant X3
protein Star-like, transcript variant X1
39S ribosomal protein L39, mitochondrial-like, transcript variant X2
39S ribosomal protein L39, mitochondrial-like, transcript variant X1
39S ribosomal protein L39, mitochondrial-like isoform X2
39S ribosomal protein L39, mitochondrial-like isoform X1
uncharacterized LOC123508416, transcript variant X2
uncharacterized LOC123508416, transcript variant X1
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
neuroligin-1-like, transcript variant X4
neuroligin-1-like, transcript variant X1
neuroligin-1-like, transcript variant X3
neuroligin-1-like, transcript variant X2
neuroligin-1-like, transcript variant X5
uncharacterized protein DKFZp434B061-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123508088, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123508088, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123508088, transcript variant X2
uncharacterized LOC123508088, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123508088, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
LOW QUALITY PROTEIN: integumentary mucin C.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
long-chain-fatty-acid--CoA ligase 4-like, transcript variant X1
long-chain-fatty-acid--CoA ligase 4-like, transcript variant X2
long-chain-fatty-acid--CoA ligase 4-like, transcript variant X3
long-chain-fatty-acid--CoA ligase 4-like isoform X1
long-chain-fatty-acid--CoA ligase 4-like isoform X2
uncharacterized LOC123508452, transcript variant X2
uncharacterized LOC123508452, transcript variant X1
spore coat protein SP87-like, transcript variant X3
spore coat protein SP87-like, transcript variant X2
spore coat protein SP87-like, transcript variant X4
spore coat protein SP87-like, transcript variant X1
uncharacterized protein LOC123508149 isoform X2
uncharacterized protein LOC123508149 isoform X4
uncharacterized protein LOC123508149 isoform X1
kielin/chordin-like protein, transcript variant X3
kielin/chordin-like protein, transcript variant X2
kielin/chordin-like protein, transcript variant X1
uncharacterized LOC123508150, transcript variant X1
uncharacterized LOC123508150, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
tetratricopeptide repeat protein 21B-like
uncharacterized LOC123508223, transcript variant X3
uncharacterized LOC123508223, transcript variant X2
uncharacterized LOC123508223, transcript variant X1
uncharacterized protein LOC123508223 isoform X2
uncharacterized protein LOC123508223 isoform X1
uncharacterized protein LOC123508223 isoform X3
uncharacterized LOC123508031, transcript variant X2
uncharacterized LOC123508031, transcript variant X1
uncharacterized protein LOC123508031 isoform X1
uncharacterized protein LOC123508031 isoform X2
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X8
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X12
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X10
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X7
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X5
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X13
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X6
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X4
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X11
heterogeneous nuclear ribonucleoprotein C-like, transcript variant X9
uncharacterized protein LOC123508029 isoform X7
uncharacterized protein LOC123508029 isoform X6
uncharacterized protein LOC123508029 isoform X3
heterogeneous nuclear ribonucleoprotein C-like isoform X5
uncharacterized protein LOC123508029 isoform X4
uncharacterized protein LOC123508029 isoform X2
uncharacterized protein LOC123508029 isoform X1
uncharacterized protein LOC123508029 isoform X8
uncharacterized protein LOC123508029 isoform X10
uncharacterized protein LOC123508029 isoform X9
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 64% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC123508164
uncharacterized protein DDB_G0287625-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase 24-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WASH complex subunit 5-like, transcript variant X6
WASH complex subunit 5-like, transcript variant X1
WASH complex subunit 5-like, transcript variant X7
WASH complex subunit 5-like, transcript variant X4
WASH complex subunit 5-like, transcript variant X3
WASH complex subunit 5-like, transcript variant X5
WASH complex subunit 5-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X14
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X9
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X16
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X6
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X7
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X5
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X4
heterogeneous nuclear ribonucleoprotein R-like isoform X10
heterogeneous nuclear ribonucleoprotein R-like isoform X12
heterogeneous nuclear ribonucleoprotein R-like isoform X7
heterogeneous nuclear ribonucleoprotein Q-like isoform X2
heterogeneous nuclear ribonucleoprotein Q-like isoform X1
heterogeneous nuclear ribonucleoprotein Q-like isoform X3
heterogeneous nuclear ribonucleoprotein R-like isoform X6
heterogeneous nuclear ribonucleoprotein R-like isoform X8
heterogeneous nuclear ribonucleoprotein R-like isoform X4
heterogeneous nuclear ribonucleoprotein R-like isoform X5
heterogeneous nuclear ribonucleoprotein R-like isoform X9
heterogeneous nuclear ribonucleoprotein R-like, transcript variant X13
heterogeneous nuclear ribonucleoprotein R-like isoform X11
uncharacterized LOC123508349, transcript variant X2
uncharacterized LOC123508349, transcript variant X1
facilitated trehalose transporter Tret1-like
dolichyl-phosphate beta-glucosyltransferase-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
cell growth regulator with RING finger domain protein 1-like, transcript variant X2
cell growth regulator with RING finger domain protein 1-like, transcript variant X1
cell growth regulator with RING finger domain protein 1-like
lipid droplet localized protein-like, transcript variant X2
lipid droplet localized protein-like, transcript variant X1
lipid droplet localized protein-like, transcript variant X4
lipid droplet localized protein-like isoform X1
lipid droplet localized protein-like, transcript variant X3
lipid droplet localized protein-like, transcript variant X5
lipid droplet localized protein-like isoform X2
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium- and chloride-dependent glycine transporter 1-like isoform X1
sodium- and chloride-dependent glycine transporter 1-like isoform X2
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
sodium- and chloride-dependent glycine transporter 1-like isoform X3
methionine aminopeptidase 1-like, transcript variant X14
methionine aminopeptidase 1-like, transcript variant X2
methionine aminopeptidase 1-like, transcript variant X6
methionine aminopeptidase 1-like, transcript variant X9
methionine aminopeptidase 1-like, transcript variant X4
methionine aminopeptidase 1-like, transcript variant X15
methionine aminopeptidase 1-like, transcript variant X12
methionine aminopeptidase 1-like, transcript variant X13
methionine aminopeptidase 1-like, transcript variant X11
methionine aminopeptidase 1-like, transcript variant X1
methionine aminopeptidase 1-like, transcript variant X5
methionine aminopeptidase 1-like, transcript variant X7
methionine aminopeptidase 1-like, transcript variant X3
methionine aminopeptidase 1-like, transcript variant X8
methionine aminopeptidase 1-like, transcript variant X10
methionine aminopeptidase 1-like isoform X6
methionine aminopeptidase 1-like isoform X4
methionine aminopeptidase 1-like isoform X3
methionine aminopeptidase 1-like isoform X1
methionine aminopeptidase 1-like isoform X5
methionine aminopeptidase 1-like isoform X2
methionine aminopeptidase 1-like isoform X7
tigger transposable element-derived protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA topoisomerase 2-alpha-like, transcript variant X1
DNA topoisomerase 2-alpha-like, transcript variant X3
DNA topoisomerase 2-alpha-like, transcript variant X2
DNA topoisomerase 2-alpha-like, transcript variant X4
DNA topoisomerase 2-alpha-like isoform X2
DNA topoisomerase 2-alpha-like isoform X4
DNA topoisomerase 2-alpha-like isoform X1
DNA topoisomerase 2-alpha-like isoform X3
LOW QUALITY PROTEIN: tryptase beta-2-like
FAD-dependent oxidoreductase domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X1
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X2
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X11
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X5
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X14
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X7
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X13
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X12
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X3
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X4
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X6
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X15
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X9
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X17
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X8
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X20
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X10
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X19
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X18
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X21
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X22
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X5
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X9
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like isoform X18
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X11
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X1
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X7
phosphatidylinositol 4-phosphate 5-kinase type-1 beta-like isoform X13
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X12
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X3
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like isoform X15
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X8
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like isoform X16
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X6
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X10
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like isoform X19
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X14
phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like isoform X17
LOW QUALITY PROTEIN: uncharacterized protein LOC123508372
N-lysine methyltransferase SMYD2-like, transcript variant X2
N-lysine methyltransferase SMYD2-like, transcript variant X3
SET and MYND domain-containing protein DDB_G0292140-like isoform X2
N-lysine methyltransferase SMYD2-like, transcript variant X1
SET and MYND domain-containing protein DDB_G0292140-like isoform X1
N-lysine methyltransferase SMYD2-like isoform X3
VWFA and cache domain-containing protein 1-like, transcript variant X2
VWFA and cache domain-containing protein 1-like, transcript variant X1
VWFA and cache domain-containing protein 1-like, transcript variant X3
VWFA and cache domain-containing protein 1-like
peptidyl-prolyl cis-trans isomerase FKBP4-like
tight junction protein ZO-1-like, transcript variant X14
tight junction protein ZO-1-like, transcript variant X11
tight junction protein ZO-1-like, transcript variant X6
tight junction protein ZO-1-like, transcript variant X9
tight junction protein ZO-1-like, transcript variant X5
tight junction protein ZO-1-like, transcript variant X2
tight junction protein ZO-1-like, transcript variant X13
tight junction protein ZO-1-like, transcript variant X3
tight junction protein ZO-1-like, transcript variant X1
tight junction protein ZO-1-like, transcript variant X7
tight junction protein ZO-1-like, transcript variant X4
tight junction protein ZO-1-like, transcript variant X16
tight junction protein ZO-1-like, transcript variant X15
tight junction protein ZO-1-like, transcript variant X17
tight junction protein ZO-1-like, transcript variant X18
tight junction protein ZO-1-like, transcript variant X10
tight junction protein ZO-1-like, transcript variant X8
tight junction protein ZO-1-like, transcript variant X20
tight junction protein ZO-1-like, transcript variant X19
tight junction protein ZO-1-like isoform X14
tight junction protein ZO-1-like isoform X11
tight junction protein ZO-1-like isoform X9
tight junction protein ZO-1-like isoform X6
tight junction protein ZO-1-like isoform X5
tight junction protein ZO-1-like isoform X2
tight junction protein ZO-1-like isoform X13
tight junction protein ZO-1-like isoform X3
tight junction protein ZO-1-like isoform X1
tight junction protein ZO-1-like isoform X7
tight junction protein ZO-1-like isoform X4
tight junction protein ZO-1-like isoform X15
tight junction protein ZO-1-like isoform X10
tight junction protein ZO-1-like isoform X8
tight junction protein ZO-1-like isoform X17
tight junction protein ZO-1-like isoform X16
tight junction protein ZO-1-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tight junction protein ZO-2-like isoform X12
ankyrin repeat domain-containing protein 13D-like, transcript variant X2
ankyrin repeat domain-containing protein 13D-like, transcript variant X1
ankyrin repeat domain-containing protein 13D-like
protein zer-1 homolog, transcript variant X1
protein zer-1 homolog, transcript variant X2
uncharacterized LOC123507996, transcript variant X2
uncharacterized LOC123507996, transcript variant X1
uncharacterized protein LOC123507996 isoform X2
uncharacterized protein LOC123507996 isoform X1
uncharacterized LOC123507999, transcript variant X2
uncharacterized LOC123507999, transcript variant X1
uncharacterized protein LOC123507999 isoform X2
uncharacterized protein LOC123507999 isoform X1
LOW QUALITY PROTEIN: adenosine deaminase 2-like
adenosine deaminase 2-like, transcript variant X2
adenosine deaminase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
tigger transposable element-derived protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
acyl-coenzyme A thioesterase 9, mitochondrial-like, transcript variant X3
acyl-coenzyme A thioesterase 9, mitochondrial-like, transcript variant X2
acyl-coenzyme A thioesterase 9, mitochondrial-like, transcript variant X1
acyl-coenzyme A thioesterase 9, mitochondrial-like isoform X2
acyl-coenzyme A thioesterase 9, mitochondrial-like isoform X1
acyl-coenzyme A thioesterase 9, mitochondrial-like isoform X3
acyl-coenzyme A thioesterase 9, mitochondrial-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
acyl-coenzyme A thioesterase 9, mitochondrial-like isoform X4
ATP-binding cassette sub-family F member 2-like, transcript variant X2
ATP-binding cassette sub-family F member 2-like, transcript variant X1
ATP-binding cassette sub-family F member 2-like
trafficking protein particle complex subunit 13-like, transcript variant X3
trafficking protein particle complex subunit 13-like, transcript variant X1
trafficking protein particle complex subunit 13-like, transcript variant X4
trafficking protein particle complex subunit 13-like, transcript variant X2
trafficking protein particle complex subunit 13-like isoform X2
trafficking protein particle complex subunit 13-like isoform X1
trafficking protein particle complex subunit 13-like isoform X3
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
putative uncharacterized protein YHR217C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 93% coverage of the annotated genomic feature by RNAseq alignments
DNA translocase FtsK-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DNA translocase FtsK-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA translocase FtsK-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC123508226, transcript variant X1
uncharacterized LOC123508226, transcript variant X3
uncharacterized LOC123508226, transcript variant X2
glutamate receptor ionotropic, delta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
CREB-regulated transcription coactivator 1-like, transcript variant X3
CREB-regulated transcription coactivator 1-like, transcript variant X1
CREB-regulated transcription coactivator 1-like, transcript variant X2
CREB-regulated transcription coactivator 1-like, transcript variant X4
CREB-regulated transcription coactivator 1-like, transcript variant X5
histone lysine acetyltransferase CREBBP-like isoform X1
dual specificity protein kinase splA-like isoform X2
CREB-regulated transcription coactivator 1-like isoform X4
CREB-regulated transcription coactivator 1-like isoform X5
hybrid signal transduction histidine kinase B-like isoform X3
putative pre-mRNA-splicing factor ATP-dependent RNA helicase PRP1, transcript variant X2
putative pre-mRNA-splicing factor ATP-dependent RNA helicase PRP1, transcript variant X1
putative pre-mRNA-splicing factor ATP-dependent RNA helicase PRP1 isoform X2
putative pre-mRNA-splicing factor ATP-dependent RNA helicase PRP1 isoform X1
ER degradation-enhancing alpha-mannosidase-like protein 2
developmental regulatory protein wetA-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123508284
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LOW QUALITY PROTEIN: protein bric-a-brac 1-like
uncharacterized LOC123508294, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123508294, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
GDNF-inducible zinc finger protein 1-like, transcript variant X1
GDNF-inducible zinc finger protein 1-like, transcript variant X2
GDNF-inducible zinc finger protein 1-like, transcript variant X5
GDNF-inducible zinc finger protein 1-like, transcript variant X4
GDNF-inducible zinc finger protein 1-like, transcript variant X3
GDNF-inducible zinc finger protein 1-like
WAS/WASL-interacting protein family member 3-like, transcript variant X1
WAS/WASL-interacting protein family member 3-like, transcript variant X3
WAS/WASL-interacting protein family member 3-like, transcript variant X2
WAS/WASL-interacting protein family member 3-like, transcript variant X4
WAS/WASL-interacting protein family member 3-like isoform X4
WAS/WASL-interacting protein family member 3-like isoform X3
WAS/WASL-interacting protein family member 3-like isoform X2
WAS/WASL-interacting protein family member 3-like isoform X1
zinc finger protein 48-like, transcript variant X2
zinc finger protein 48-like, transcript variant X3
zinc finger protein 48-like, transcript variant X1
zinc finger protein 48-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
longitudinals lacking protein, isoforms H/M/V-like isoform X4
zinc finger and BTB domain-containing protein 7B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X1
uncharacterized protein LOC123508299 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
WD repeat-containing protein 43-like, transcript variant X3
WD repeat-containing protein 43-like, transcript variant X1
WD repeat-containing protein 43-like, transcript variant X2
WD repeat-containing protein 43-like, transcript variant X4
WD repeat-containing protein 43-like isoform X2
WD repeat-containing protein 43-like isoform X1
serine/threonine-protein kinase PLK1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
serine/threonine-protein kinase PLK1-like, transcript variant X1
serine/threonine-protein kinase PLK1-like, transcript variant X3
serine/threonine-protein kinase PLK1-like isoform X1
serine/threonine-protein kinase PLK1-like isoform X2
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X6
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X2
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X9
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X7
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X1
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X4
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X3
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X5
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X8
nuclear factor NF-kappa-B p100 subunit-like isoform X2
nuclear factor NF-kappa-B p100 subunit-like isoform X1
nuclear factor NF-kappa-B p100 subunit-like isoform X4
nuclear factor NF-kappa-B p100 subunit-like isoform X3
nuclear factor NF-kappa-B p100 subunit-like isoform X5
putative RNA-binding protein Luc7-like 1, transcript variant X1
putative RNA-binding protein Luc7-like 1, transcript variant X3
putative RNA-binding protein Luc7-like 1, transcript variant X2
putative RNA-binding protein Luc7-like 1, transcript variant X4
putative RNA-binding protein Luc7-like 1 isoform X1
putative RNA-binding protein Luc7-like 1 isoform X2
cilia- and flagella-associated protein 58-like, transcript variant X2
cilia- and flagella-associated protein 58-like, transcript variant X1
cilia- and flagella-associated protein 58-like
serine/arginine repetitive matrix protein 1-like, transcript variant X2
serine/arginine repetitive matrix protein 1-like, transcript variant X1
serine/arginine repetitive matrix protein 1-like, transcript variant X3
serine/arginine repetitive matrix protein 1-like, transcript variant X4
uncharacterized protein LOC123508305 isoform X3
uncharacterized protein LOC123508305 isoform X2
uncharacterized protein LOC123508305 isoform X1
serine/arginine repetitive matrix protein 1-like isoform X4
aspartate--tRNA ligase, cytoplasmic-like
anaphase-promoting complex subunit 5-like, transcript variant X3
anaphase-promoting complex subunit 5-like, transcript variant X1
anaphase-promoting complex subunit 5-like, transcript variant X2
anaphase-promoting complex subunit 5-like isoform X2
anaphase-promoting complex subunit 5-like isoform X1
uncharacterized LOC123508314, transcript variant X1
uncharacterized LOC123508314, transcript variant X3
uncharacterized LOC123508314, transcript variant X2
uncharacterized protein LOC123508314 isoform X1
uncharacterized protein LOC123508314 isoform X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: peroxiredoxin-like 2A
protein phosphatase 1H-like, transcript variant X3
protein phosphatase 1H-like, transcript variant X1
protein phosphatase 1H-like, transcript variant X2
inactive tyrosine-protein kinase 7-like, transcript variant X1
inactive tyrosine-protein kinase 7-like, transcript variant X2
inactive tyrosine-protein kinase 7-like, transcript variant X3
inactive tyrosine-protein kinase 7-like isoform X1
inactive tyrosine-protein kinase 7-like isoform X2
inactive tyrosine-protein kinase 7-like isoform X3
aromatic-L-amino-acid decarboxylase-like, transcript variant X2
aromatic-L-amino-acid decarboxylase-like, transcript variant X1
aromatic-L-amino-acid decarboxylase-like isoform X1
aromatic-L-amino-acid decarboxylase-like, transcript variant X3
aromatic-L-amino-acid decarboxylase-like isoform X2
aromatic-L-amino-acid decarboxylase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
3-hydroxyisobutyrate dehydrogenase, mitochondrial-like
LOW QUALITY PROTEIN: 3-hydroxyisobutyrate dehydrogenase, mitochondrial-like
gelsolin-related protein of 125 kDa-like, transcript variant X1
gelsolin-related protein of 125 kDa-like, transcript variant X2
gelsolin-related protein of 125 kDa-like
two pore calcium channel protein 1-like, transcript variant X3
two pore calcium channel protein 1-like, transcript variant X2
two pore calcium channel protein 1-like, transcript variant X1
two pore calcium channel protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
two pore calcium channel protein 1-like isoform X1
two pore calcium channel protein 1-like isoform X2
uncharacterized oxidoreductase TM_0325-like, transcript variant X1
uncharacterized oxidoreductase TM_0325-like, transcript variant X2
uncharacterized LOC123508042, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized LOC123508042, transcript variant X2
uncharacterized oxidoreductase TM_0325-like
ABC transporter F family member 4-like, transcript variant X3
ABC transporter F family member 4-like, transcript variant X1
ABC transporter F family member 4-like, transcript variant X2
uncharacterized LOC123508234, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC123508234, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123508234, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC123508234 isoform X1
uncharacterized protein LOC123508234 isoform X2
ras-related protein Rab-28-like, transcript variant X1
ras-related protein Rab-28-like, transcript variant X2
uncharacterized LOC123508083, transcript variant X3
uncharacterized LOC123508083, transcript variant X1
uncharacterized LOC123508083, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 33-like
uncharacterized LOC123508278, transcript variant X1
uncharacterized LOC123508278, transcript variant X2
uncharacterized LOC123508278, transcript variant X3
uncharacterized protein LOC123508278 isoform X2
uncharacterized protein LOC123508278 isoform X1
uncharacterized protein LOC123508278 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein Wnt-16-like, transcript variant X1
protein Wnt-16-like, transcript variant X2
protein Wnt-16-like, transcript variant X3
protein Wnt-16-like, transcript variant X4
uncharacterized LOC123508206, transcript variant X2
uncharacterized LOC123508206, transcript variant X1
uncharacterized LOC123508206, transcript variant X3
putative diacyglycerol O-acyltransferase MT1468
vitelline membrane outer layer protein 1 homolog
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X4
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X2
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X3
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X7
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like isoform X7
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X5
protein Wnt-2b-A-like, transcript variant X2
protein Wnt-2b-A-like, transcript variant X3
protein Wnt-2b-A-like, transcript variant X4
protein Wnt-2b-A-like, transcript variant X1
DNA replication factor Cdt1-like, transcript variant X2
DNA replication factor Cdt1-like, transcript variant X1
DNA replication factor Cdt1-like isoform X2
DNA replication factor Cdt1-like isoform X1
ADP-ribosylation factor-like protein 4C, transcript variant X1
ADP-ribosylation factor-like protein 4C, transcript variant X2
zinc finger CCCH domain-containing protein 18-like
protein NEDD1-like, transcript variant X1
protein NEDD1-like, transcript variant X2
protein NEDD1-like, transcript variant X4
protein NEDD1-like, transcript variant X5
protein NEDD1-like, transcript variant X3
early growth response protein 1-B-like, transcript variant X2
early growth response protein 1-B-like, transcript variant X3
early growth response protein 1-B-like, transcript variant X1
early growth response protein 1-B-like isoform X2
early growth response protein 1-B-like isoform X3
early growth response protein 1-B-like isoform X1
tetraspanin-5-like, transcript variant X1
tetraspanin-5-like, transcript variant X2
tetraspanin-5-like, transcript variant X3
uncharacterized LOC123508074, transcript variant X2
uncharacterized LOC123508074, transcript variant X5
uncharacterized LOC123508074, transcript variant X1
uncharacterized LOC123508074, transcript variant X3
uncharacterized LOC123508074, transcript variant X4
uncharacterized protein LOC123508074 isoform X2
uncharacterized protein LOC123508074 isoform X1
flocculation protein FLO11-like, transcript variant X2
flocculation protein FLO11-like, transcript variant X3
flocculation protein FLO11-like, transcript variant X1
flocculation protein FLO11-like isoform X1
flocculation protein FLO11-like isoform X2
flocculation protein FLO11-like isoform X3
cell wall protein DAN4-like, transcript variant X2
cell wall protein DAN4-like, transcript variant X1
cell wall protein DAN4-like, transcript variant X3
protein pygopus-like, transcript variant X2
protein pygopus-like, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123508219, transcript variant X2
uncharacterized LOC123508219, transcript variant X1
hemicentin-1-like, transcript variant X2
hemicentin-1-like, transcript variant X1
vitelline membrane outer layer protein 1-like
galactose-specific lectin nattectin-like
FAD synthase-like, transcript variant X2
FAD synthase-like, transcript variant X3
FAD synthase-like, transcript variant X1
methyltransferase-like protein 17, mitochondrial, transcript variant X6
methyltransferase-like protein 17, mitochondrial, transcript variant X5
methyltransferase-like protein 17, mitochondrial, transcript variant X3
methyltransferase-like protein 17, mitochondrial, transcript variant X7
methyltransferase-like protein 17, mitochondrial, transcript variant X8
methyltransferase-like protein 17, mitochondrial, transcript variant X1
methyltransferase-like protein 17, mitochondrial, transcript variant X4
methyltransferase-like protein 17, mitochondrial, transcript variant X2
methyltransferase-like protein 17, mitochondrial isoform X1
methyltransferase-like protein 17, mitochondrial isoform X2
venom dipeptidyl peptidase 4-like, transcript variant X5
venom dipeptidyl peptidase 4-like, transcript variant X2
venom dipeptidyl peptidase 4-like, transcript variant X4
venom dipeptidyl peptidase 4-like, transcript variant X3
venom dipeptidyl peptidase 4-like, transcript variant X1
venom dipeptidyl peptidase 4-like, transcript variant X6
venom dipeptidyl peptidase 4-like isoform X3
venom dipeptidyl peptidase 4-like isoform X2
venom dipeptidyl peptidase 4-like isoform X1
venom dipeptidyl peptidase 4-like isoform X4
bone morphogenetic protein receptor type-2-like, transcript variant X5
bone morphogenetic protein receptor type-2-like, transcript variant X4
bone morphogenetic protein receptor type-2-like, transcript variant X2
bone morphogenetic protein receptor type-2-like, transcript variant X3
bone morphogenetic protein receptor type-2-like, transcript variant X1
bone morphogenetic protein receptor type-2-like isoform X5
bone morphogenetic protein receptor type-2-like isoform X4
bone morphogenetic protein receptor type-2-like isoform X2
bone morphogenetic protein receptor type-2-like isoform X3
bone morphogenetic protein receptor type-2-like isoform X1
mitochondrial Rho GTPase-like, transcript variant X3
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mitochondrial Rho GTPase-like, transcript variant X1
mitochondrial Rho GTPase-like, transcript variant X4
mitochondrial Rho GTPase-like, transcript variant X5
mitochondrial Rho GTPase-like, transcript variant X6
mitochondrial Rho GTPase-like, transcript variant X2
mitochondrial Rho GTPase 1-like isoform X1
mitochondrial Rho GTPase-like isoform X3
mitochondrial Rho GTPase 1-like isoform X2
mitochondrial Rho GTPase-like isoform X4
TATA-binding protein-associated factor 172-like
glycine-rich cell wall structural protein 1.8-like
glutamate dehydrogenase, mitochondrial-like, transcript variant X4
glutamate dehydrogenase, mitochondrial-like, transcript variant X1
glutamate dehydrogenase, mitochondrial-like, transcript variant X3
glutamate dehydrogenase, mitochondrial-like, transcript variant X2
glutamate dehydrogenase, mitochondrial-like isoform X1
glutamate dehydrogenase, mitochondrial-like isoform X3
glutamate dehydrogenase, mitochondrial-like isoform X2
glutamate dehydrogenase, mitochondrial-like isoform X4
RUN and FYVE domain-containing protein 2-like, transcript variant X10
RUN and FYVE domain-containing protein 2-like isoform X3
RUN and FYVE domain-containing protein 2-like, transcript variant X7
RUN and FYVE domain-containing protein 2-like, transcript variant X8
RUN and FYVE domain-containing protein 2-like, transcript variant X5
RUN and FYVE domain-containing protein 2-like, transcript variant X6
RUN and FYVE domain-containing protein 2-like, transcript variant X4
RUN and FYVE domain-containing protein 2-like, transcript variant X1
RUN and FYVE domain-containing protein 2-like, transcript variant X3
RUN and FYVE domain-containing protein 2-like, transcript variant X2
RUN and FYVE domain-containing protein 2-like, transcript variant X9
RUN and FYVE domain-containing protein 2-like isoform X1
RUN and FYVE domain-containing protein 2-like isoform X2
endoribonuclease Dcr-1-like, transcript variant X2
endoribonuclease Dcr-1-like, transcript variant X1
intraflagellar transport protein 20 homolog, transcript variant X2
intraflagellar transport protein 20 homolog, transcript variant X1
intraflagellar transport protein 20 homolog
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3-like, transcript variant X1
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3-like isoform X1
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3-like, transcript variant X2
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3-like isoform X2
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3-like, transcript variant X3
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3-like isoform X3
pre-mRNA-splicing factor SLU7-like, transcript variant X2
pre-mRNA-splicing factor SLU7-like, transcript variant X1
acyl carrier protein, mitochondrial-like
H/ACA ribonucleoprotein complex subunit 1-like
LOW QUALITY PROTEIN: H/ACA ribonucleoprotein complex subunit 1-like
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X2
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X1
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X3
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X6
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X5
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X4
E3 ubiquitin-protein ligase RFWD3-like isoform X4
E3 ubiquitin-protein ligase RFWD3-like isoform X3
E3 ubiquitin-protein ligase RFWD3-like isoform X2
E3 ubiquitin-protein ligase RFWD3-like isoform X1
uncharacterized LOC123508122, transcript variant X3
uncharacterized LOC123508122, transcript variant X4
uncharacterized LOC123508122, transcript variant X2
uncharacterized LOC123508122, transcript variant X1
uncharacterized LOC123508130, transcript variant X1
uncharacterized LOC123508130, transcript variant X2
uncharacterized LOC123508130, transcript variant X3
leukocyte receptor cluster member 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC123508125, transcript variant X3
uncharacterized LOC123508125, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC123508125 isoform X2
uncharacterized protein LOC123508125 isoform X3
uncharacterized LOC123508125, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized protein LOC123508125 isoform X1
SUMO-conjugating enzyme UBC9-B, transcript variant X1
SUMO-conjugating enzyme UBC9-B, transcript variant X3
SUMO-conjugating enzyme UBC9-B, transcript variant X2
SUMO-conjugating enzyme UBC9-B, transcript variant X4
uncharacterized LOC123508134, transcript variant X9
uncharacterized LOC123508134, transcript variant X2
uncharacterized LOC123508134, transcript variant X10
uncharacterized LOC123508134, transcript variant X7
uncharacterized LOC123508134, transcript variant X1
uncharacterized LOC123508134, transcript variant X3
uncharacterized LOC123508134, transcript variant X5
uncharacterized LOC123508134, transcript variant X8
uncharacterized LOC123508134, transcript variant X6
uncharacterized LOC123508134, transcript variant X4
uncharacterized protein LOC123508134 isoform X1
uncharacterized LOC123508134, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC123508134 isoform X2
heat shock 70 kDa protein 4-like, transcript variant X2
heat shock 70 kDa protein 4-like, transcript variant X1
heat shock 70 kDa protein 4-like isoform X2
heat shock 70 kDa protein 4-like isoform X1
serine/threonine-protein kinase PLK4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/threonine-protein kinase PLK4-like, transcript variant X2
serine/threonine-protein kinase PLK4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein kinase PLK4-like isoform X1
serine/threonine-protein kinase PLK4-like isoform X2
serine/threonine-protein kinase PLK4-like isoform X3
formin-like protein 15, transcript variant X1
formin-like protein 15, transcript variant X2
ADP-ribosylation factor-like protein 6-interacting protein 1, transcript variant X1
ADP-ribosylation factor-like protein 6-interacting protein 1, transcript variant X2
ADP-ribosylation factor-like protein 6-interacting protein 1
LOW QUALITY PROTEIN: uncharacterized protein LOC123508440
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X3
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X1
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X4
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X8
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X9
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X12
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X10
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X11
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X15
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X6
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X2
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X5
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X4
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X5
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X7
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X11
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X1
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X9
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X10
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X3
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X2
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X7
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X14
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X8
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X6
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X13
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X12
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X14
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
probable cytochrome P450 CYP44, transcript variant X1
probable cytochrome P450 CYP44, transcript variant X2
probable cytochrome P450 CYP44 isoform X1
probable cytochrome P450 CYP44 isoform X2
uncharacterized LOC123508316, transcript variant X5
uncharacterized LOC123508316, transcript variant X6
uncharacterized LOC123508316, transcript variant X4
uncharacterized LOC123508316, transcript variant X1
uncharacterized LOC123508316, transcript variant X3
uncharacterized LOC123508316, transcript variant X2
uncharacterized protein LOC123508316 isoform X4
uncharacterized protein LOC123508316 isoform X2
uncharacterized protein LOC123508316 isoform X3
uncharacterized protein LOC123508316 isoform X1
dopamine receptor 2-like, transcript variant X1
dopamine receptor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gamma-secretase subunit Aph-1-like, transcript variant X2
gamma-secretase subunit Aph-1-like, transcript variant X1
gamma-secretase subunit Aph-1-like isoform X2
gamma-secretase subunit Aph-1-like isoform X1
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
WSC domain-containing protein 2-like, transcript variant X3
WSC domain-containing protein 2-like, transcript variant X1
WSC domain-containing protein 2-like, transcript variant X2
WSC domain-containing protein 2-like isoform X3
uncharacterized protein LOC123508025 isoform X1
uncharacterized protein LOC123508025 isoform X2